Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Current Leases (2016 - 2025)

Historic Current Leases for Aspen Aerogels (ASPN) over the last 12 years, with Q3 2025 value amounting to $3.2 million.

  • Aspen Aerogels' Current Leases rose 194.91% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 194.91%. This contributed to the annual value of $3.3 million for FY2024, which is 7497.33% up from last year.
  • Latest data reveals that Aspen Aerogels reported Current Leases of $3.2 million as of Q3 2025, which was up 194.91% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, Aspen Aerogels' Current Leases peaked at $3.3 million during Q1 2025, and registered a low of $1.2 million during Q1 2021.
  • Its 5-year average for Current Leases is $2.4 million, with a median of $2.3 million in 2023.
  • Its Current Leases has fluctuated over the past 5 years, first surged by 12007.58% in 2021, then tumbled by 2196.74% in 2024.
  • Over the past 5 years, Aspen Aerogels' Current Leases (Quarter) stood at $2.2 million in 2021, then rose by 5.38% to $2.4 million in 2022, then fell by 20.86% to $1.9 million in 2023, then surged by 74.97% to $3.3 million in 2024, then decreased by 1.1% to $3.2 million in 2025.
  • Its Current Leases stands at $3.2 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.3 million for Q1 2025.